AT & S Austria Technologie & Systemtechnik Aktiengesellschaft (LON:0O5C)
27.75
-1.10 (-3.81%)
At close: Nov 14, 2025
LON:0O5C Revenue
AT & S Austria Technologie & Systemtechnik Aktiengesellschaft had revenue of 447.39M EUR in the quarter ending September 30, 2025, a decrease of -0.70%. This brings the company's revenue in the last twelve months to 1.64B, up 6.53% year-over-year. In the fiscal year ending March 31, 2025, AT & S Austria Technologie & Systemtechnik Aktiengesellschaft had annual revenue of 1.59B with 2.57% growth.
Revenue (ttm)
1.64B EUR
Revenue Growth
+6.53%
P/S Ratio
0.67
Revenue / Employee
130.63K EUR
Employees
12,524
Market Cap
951.68M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.59B | 39.85M | 2.57% |
| Mar 31, 2024 | 1.55B | -241.57M | -13.49% |
| Mar 31, 2023 | 1.79B | 201.48M | 12.67% |
| Mar 31, 2022 | 1.59B | 401.64M | 33.80% |
| Mar 31, 2021 | 1.19B | 187.65M | 18.75% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |